Financial Health Assessment: MARSHALL WALKER (NEWARK) LIMITED

1. Financial Health Score: B+

Explanation: The company is exhibiting a strong recovery after a period of significant financial deterioration. While the balance sheet has stabilized and liquidity is excellent, the relatively small scale of operations and the historical volatility in net assets prevent a top-tier rating. The patient has successfully pulled out of a downward spiral, but needs to maintain this healthier trajectory to build long-term resilience.

2. Key Vital Signs

• Net Asset Pulse (Equity Health): £7,690 (Up from £1,940 in 2024)
  • Interpretation: The company’s "blood pressure" has normalized. After bleeding equity from 2019 (£17,796) down to a dangerously low £1,779 in 2023, the latest figures show a much-needed transfusion of £5,750 in retained profits over the last year.
• Current Ratio (Liquidity/Oxygen Levels): 5.02x (£11,912 Current Assets / £2,372 Current Liabilities)
  • Interpretation: The business is breathing easily. With over £5 in short-term assets for every £1 of short-term debt due, there are no immediate signs of respiratory distress or cash crunches.
• Liability Reduction (Cholesterol Levels): Total liabilities dropped from £14,668 to £4,222
  • Interpretation: The company has been on a strict financial diet, aggressively paying down both short-term and long-term creditors. The "bad cholesterol" (debt) has been reduced by over 70%, significantly lowering financial stress on the heart of the business.
• Scale & Activity (Metabolic Rate): 0 Employees, Micro-entity
  • Interpretation: This is a sole practitioner practice (Accounting/Auditing). The metabolic rate is low; it is a lean operation relying entirely on the director's personal output.

3. Diagnosis

Condition: Recovering from Chronic Equity Erosion, currently in Remission

The financial data reveals a business that suffered a prolonged period of "chronic illness" between 2019 and 2023, where net assets deteriorated significantly from £17,796 to £1,779. This suggests either sustained trading losses or the director extracting value from the company during that period.

However, the latest period (ending Nov 2025) shows a remarkable "immune response." The patient has not only stopped the bleeding but has generated healthy profits and used them to dramatically clear debts. The reduction in creditors due within one year (from £9,118 to £2,372) and after one year (from £5,550 to £1,850) indicates the director is actively deleveraging the business.

Because this is a micro-entity filing as an accounting practice (SIC 69201) with zero employees, the "vitality" of the company is entirely tied to the professional capacity and health of the sole director, Stephen Michael Walker. The balance sheet is now stable, but it remains lean, meaning any interruption to the director's ability to bill clients would quickly become a symptom of distress.

4. Recommendations

To ensure continued financial wellness and build a more robust constitution, the following actions are prescribed:

1. Build an Emergency Reserves Fund: While liquidity is currently strong, the business is entirely dependent on current assets (likely trade receivables or cash). Aim to maintain a minimum cash reserve equivalent to 3-6 months of operating expenses to act as a financial "safety net" should the director face a period of illness or market downturn.
2. Monitor the Remaining Long-Term Debt: The £1,850 falling due after more than one year is the last remaining "blockage." Ensure that the business has a clear plan to service or clear this debt when it matures to prevent future stress.
3. Invest in Preventative Care: With a strong current ratio and healthy cash generation, now is the time to invest in the business—whether that is in software, marketing, or professional development—to secure future revenue streams and prevent the "atrophy" seen in the 2019-2023 periods.
4. Maintain Strict Financial Hygiene: Continue the discipline of keeping creditor levels low. The reduction in liabilities is commendable and should be maintained as a standard operating procedure rather than a one-time intervention.